Document is current
Any future updates will be listed below
-
Authors
Bureau, Côme https://orcid.org/0000-0003-1597-8127
Decavèle, Maxens
Campion, Sébastien
Nierat, Marie-Cécile
Mayaux, Julien
Morawiec, Elise
Raux, Mathieu
Similowski, Thomas
Demoule, Alexandre
- License Information
-
More Information
Article History
Received: 11 September 2021
Accepted: 22 November 2021
First Online: 17 December 2021
Declarations
:
: The study was approved by the <i>Comité de Protection des Personnes Ile de France VI</i> (No. 125-15). Informed consent was obtained from patients or relatives.
: Not applicable.
: Dr. Alexandre Demoule reports personal fees from Medtronic, grants, personal fees and non-financial support from Philips, personal fees from Baxter, personal fees from Hamilton, personal fees and non-financial support from Fisher & Paykel, grants from the French Ministry of Health, personal fees from Getinge, grants and personal fees from Respinor, grants and non-financial support from Lungpacer, unrelated to the work submitted. Dr. Thomas Similowski reports (1) personal fees from ADEP Assistance, AstraZeneca France, Chiesi France, GSK France, Lungpacer Canada, Novartis France, Teva France; and (2) as a member of the board of a research association, unrestricted grants from Air Liquide Medical Systems, Covidien, Lungpacer, Maquet, and Philips, all unrelated to the present work. Dr. Similowski is listed as inventor on issued patents (WO2008006963A3, WO2012004534A1, WO2013164462A1) describing EEG responses to experimental and clinical dyspnea to identify and alleviate dyspnea in noncommunicative patients. Dr. Côme Bureau, Dr. Maxens Decavèle, Dr. Sébastien Campion, Marie-Cécile Nierat, Dr. Julien Mayaux, Dr. Elise Morawiec, Dr. Mathieu Raux have no conflicts of interest related to this work.
